Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Episode 17 with Dr. Hans Lassmann on the usefulness of animal models for studying multiple sclerosis.
Integrating Acupuncture Within a Wellness Intervention for Women With Multiple Sclerosis: A Feasibility Study.
Evaluation of No Evidence of Disease Activity in a 7-Year Longitudinal Multiple Sclerosis Cohort.
Breastfeeding is not related to postpartum relapses in multiple sclerosis.
Efficacy of treatment of MS with IFNbeta-1b or glatiramer acetate by monthly brain MRI in the BECOME study.
Multiple sclerosis in Hispanics: a study of clinical disease expression.
Frequency and magnitude of interferon β neutralizing antibodies in the evaluation of interferon β immunogenicity in patients with multiple sclerosis.
Endocannabinoids in Multiple Sclerosis and Amyotrophic Lateral Sclerosis.
Neuroscience 2014
Tumor necrosis factor alpha but not interleukin 1 beta mediates neuroprotection in response to acute nitric oxide excitotoxicity.
Reduction of CD8+ T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate
National MS Society: Research Grants
Cuprizone treatment induces demyelination and astrocytosis in the mouse hippocampus.
Novartis drug Gilenya® shows long-term efficacy and safety according to new data from extension of phase III head-to-head study
Age-related and cuprizone-induced changes in myelin and transcription factor gene expression and in oligodendrocyte cell densities in the rostral corpus callosum of mice.
MS Research Roundup: An Introduction
Neuroprotection in a novel mouse model of multiple sclerosis.
Episode 4 with Dr. Michael Racke on the Kir4.1 potassium channel
Comparative effectiveness of fingolimod versus interferons or glatiramer acetate for relapse rates in multiple sclerosis: a retrospective US claims database analysis.
Effects of dimethyl fumarate on neuroprotection and immunomodulation.
Comparison of Switch to Fingolimod or Interferon Beta/Glatiramer Acetate in Active Multiple Sclerosis.
Clinical Trials
Glia in Health & Disease
Episode 7 with Dr. Daniel Kantor on access to care
Estrogen controls vitamin D3-mediated resistance to experimental autoimmune encephalomyelitis by controlling vitamin D3 metabolism and receptor expression.

Pages